CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

IVUS Guidance for Coronary Revascularization: When to Start, When to Stop? Is Acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF Left Ventricular Rapid Pacing Via the Valve Delivery Guidewire in Transcatheter Aortic Valve Implantation Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-center A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study 3D Printing and Heart Failure: The Present and the Future SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL

Original ResearchSeptember 2019

JOURNAL:JACC Cardiovasc Interv. Article Link

Physiologic Characteristics and Clinical Outcomes of Patients With Discordance Between FFR and iFR

SH Lee, KH Choi, JM Lee et al. Keywords: coronary artery disease; coronary flow reserve; fractional flow reserve; instantaneous wave-free ratio; prognosis

ABSTRACT


OBJECTIVES - The study evaluated the physiologic characteristics of discordant lesions between instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR) and the prognosis at 5 years.

 

BACKGROUND - FFR or iFR have been standard methods for assessing the functional significance of coronary artery stenosis. However, limited data exist about the physiologic characteristics of discordant lesions and the prognostic implications resulting from these lesions.

 

METHODS - A total of 840 vessels from 596 patients were classified according to iFR and FFR; high iFRhigh FFR (n = 580), low iFRhigh FFR (n = 40), high iFRlow FFR (n = 69), and low iFRlow FFR (n = 128) groups, which were compared with a control group (n = 23). The differences in coronary circulatory indices including the coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and resistance reserve ratio (RRR) (resting distal arterial pressure × mean transit time / hyperemic distal arterial pressure × hyperemic mean transit time), which reflect the vasodilatory capacity of coronary microcirculation, were compared. Patient-oriented composite outcomes (POCO) at 5 years including all-cause death, any myocardial infarction, and any revascularization were compared among patients with deferred lesions.

 

RESULTS- In the low iFRhigh FFR group, CFR, RRR, and IMR measurements were similar to the low iFRlow FFR group: CFR 2.71 versus 2.43 (p = 0.144), RRR 3.36 versus 3.68 (p = 0.241), and IMR 18.51 versus 17.38 (p = 0.476). In the high iFRlow FFR group, the CFR, RRR, and IMR measurements were similar to the control group: CFR 2.95 versus 3.29 (p = 0.160), RRR 4.28 versus 4.00 (p = 0.414), and IMR 17.44 versus 17.06 (p = 0.818). Among the 4 groups, classified by iFR and FFR, CFR and RRR were all significantly different, except for IMR. However, there were no significant differences in the rates of POCO, regardless of discordance between the iFR and FFR. Only the low iFRlow FFR group had a higher POCO rate compared with the high iFRhigh FFR group (adjusted hazard ratio: 2.46; 95% confidence interval: 1.17 to 5.16; p = 0.018).

 

CONCLUSIONS-  Differences in coronary circulatory function were found, especially in the vasodilatory capacity between the low iFRhigh FFR and high iFRlow FFR groups. FFRiFR discordance was not related to an increased risk of POCO among patients with deferred lesions at 5 years. (Clinical, Physiological and Prognostic Implication of Microvascular Status; NCT02186093; Physiologic Assessment of Microvascular Function in Heart Transplant Patients; NCT02798731)